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Background: Insampaedok-san (ren-shen-bai-du-san in Chinese) is a traditional herbal formula widely used for the
treatment of respiratory diseases in Korea and China. In this study, we investigated the acute oral toxicity of an
Insampaedok-san water extract (ISSE) in rats and the antiasthmatic effects of ISSE and its mechanism in a model of
asthma induced by ovalbumin (OVA) in mice.
Methods: In a safety study, ISSE was administrated orally to rats of both sexes at single doses of 0 and 5000 mg/kg.
We observed body weight changes, mortality, clinical signs, and gross pathological findings. In vitro antioxidant activity
of ISSE was measured using 2,2-diphenyl-2-picrylhydrazyl and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid
radical scavenging methods. A model of asthma was established in mice by sensitization and challenge with OVA. We
assessed the levels of type 2 T-helper cytokines, chemokines, and immunoglobulin levels, using enzyme-linked
immunosorbent assays, and superoxide dismutase (SOD) activity using a kit.
Results: No adverse effects were observed in the acute ISSE toxicity study. ISSE showed potent free radical scavenging
activity and inhibited the recruitment of inflammatory cells into the lung and mucus hypersecretion in OVA-challenged
mice. ISSE significantly decreased levels of interleukin (IL)-4, IL-5, eotaxin, and OVA-specific immunoglobulin (Ig)E, and
increased SOD activity.
Conclusions: These results indicate that ISSE is safe for human consumption and its antiasthmatic effect is associated
with the ability of ISSE to attenuate inflammation and oxidative stress.
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Asthma is a chronic inflammatory disease of the airways.
The pathological changes in asthma include airway ob-
struction, mucus hyperproduction, and increased infiltra-
tion of inflammatory cells, including eosinophils, mast
cells, and lymphocytes [1]. Type 2 T-helper (Th2) cells ac-
tivated by allergens play a pivotal role in the development
of asthma. Activated Th2 cells produce various cytokines,
including interleukin (IL)-4, IL-5, and IL-13, which induce* Correspondence: cozy37@gmail.com
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unless otherwise stated.activation and recruitment of inflammatory cells, and over-
production of mucus, during the inflammatory process in
asthma. Th2 cytokines can also lead to the production of
allergen-specific immunoglobulin (Ig)E antibodies by B
cells [2,3]. Inflammation in the airways induces oxidative
damage. Activated immune cells, such as macrophages,
neutrophils, and lymphocytes, release reactive oxygen spe-
cies (ROS) [4]. Airway cells and tissues are also exposed to
exogenous ROS stress from air pollutants and cigarette
smoke [5]. Increased oxidative stress exacerbates inflam-
mation by inducing proinflammatory mediators and con-
tributes to the development of asthma [6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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is a traditional herbal formula widely used for the treat-
ment of common cold-related symptoms in Korea and
China [7]. There are several case studies demonstrating
the efficacy of ISS for respiratory diseases, such as the
common cold and asthma [8-11]. It has been reported that
the administration of this herbal medicine effectively at-
tenuates symptoms of asthma and reduces the rate of
relapse [10,11]. Our previous in vitro study revealed that
Insampaedok-san has anti-inflammatory, anti-allergic,
and anti-obesity effects [12]. Therefore, in the present
study, we performed an acute oral toxicity study of ISS
in rats to establish a safety profile for ISS. In addition,
we examined the antioxidant activity of ISS and its anti-
asthmatic effects by using a mouse model of asthma
induced by ovalbumin (OVA) in vivo to investigate the
mechanism underlying the effectiveness of ISS in the
treatment of asthma.Methods
Preparation of the Insampaedok-san water extract (ISSE)
ISSE was prepared in our laboratory from a mixture of
chopped crude herbs (Table 1). Before performing the
study, the identity of each crude herb was confirmed by
Professor Je-Hyun Lee of Dongguk University (Gyeongju,
Korea). ISSE was extracted in distilled water at 100°C for
2 h. The solution was evaporated to dryness and freeze-
dried (extraction yield: 20.89%).Table 1 Composition of ISSE







Panax ginseng Radix 3.75 Omniherb Geumsan,
Korea
Bupleurum falcatum Radix 3.75 HMAX China
Angelica decursiva Radix 3.75 HMAX China
Ostericum koreanum Radix 3.75 HMAX China
Aralia continentalis Radix 3.75 Omniherb Yeongcheon,
Korea
Citrus aurantium Fructus 3.75 HMAX China
Platycodon
grandiflorum
Radix 3.75 Omniherb Yeongcheon,
Korea
Cnidium officinale Rhizoma 3.75 Omniherb Yeongcheon,
Korea
Poria cocos Hoelen 3.75 HMAX China
Glycyrrhiza uralensis Radix 3.75 HMAX China
Mentha arvensis Herba 3.75 Omniherb Yeongcheon,
Korea
Zingiber officinale Rhizoma 3.75 Omniherb Yeongcheon,
Korea
Total amount 45.00Animals for acute oral toxicity study
Twenty Sprague Dawley (SD) rats (5 weeks) of each sex
were obtained from the Orient Bio Co. (Seoul, Korea). They
were acclimated to laboratory conditions for 5 days and
housed three per cage in an animal experiment room where
the temperature was set at 23 ± 3°C, humidity at 50 ± 10%,
ventilation frequency at 10–20 times per hour. They had
free access to sterilized tap water and commercial rodent
chow (PMI Nutrition International, USA). This study was
performed at the Korea Institute of Toxicology (KIT)
(Daejeon, Republic of Korea) and conducted according to
guidance from the Institutional Animal Care and Use
Committee at the KRICT (accredited by AAALAC Inter-
national, 1998) under the GLP Regulations for Nonclinical
Laboratory Studies.
In a previous experiment for dose selection, we con-
ducted an acute toxicity study with three dose levels of
1250, 2500, and 5000 mg/kg. We found no signs of tox-
icity at these three dose levels. Based on these findings,
we determined 5000 mg/kg as an experimental dose for
the 15-day acute toxicity study. Both the ISSE group and
the vehicle-only control group consisted of five rats of
each sex. ISSE and distilled water (vehicle control group)
were administered to rats in the treatment and control
group, respectively, via oral gavage once a day and were
observed for 15 days.
The general symptoms, signs of toxicity and mortality
were observed over 6 h after the initiation of administra-
tion, and once a day for 15 days. The body weight of
each rat was measured before the treatment and 2, 4, 8,
and 15 days after treatment. At the end of the study (day
15), all rats were sacrificed by bleeding from the abdom-
inal aorta under CO2 anesthesia and we performed gross
observation.
2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
diammonium salt (ABTS) radical scavenging activity
The ABTS radical scavenging activity of the extracts was
determined using a method described by Re et al. [13],
with slight modifications. Briefly, ABTS radical cation
was produced by reacting 7 mM ABTS solution with
2.45 mM potassium persulfate stored in the dark at
room temperature for 16 h. Prior to the assay, the solu-
tion was diluted with phosphate buffered saline (PBS,
pH 7.4) to an absorbance of 0.7 at 734 nm. Then,
ABTS⋅ + solution was added to a 96-well plate contain-
ing samples. After 5 min of incubation, the absorbance
was immediately measured at 734 nm using a micro-
plate reader (Benchmark Plus, Bio-Rad, USA). The ex-
tent of decolorization was calculated as the percentage
reduction of absorbance. The scavenging capability of
test compounds was calculated using the following
equation:
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where Acontrol was the absorbance of the negative con-
trol, and Asample was the absorbance of the standard
antioxidant or extract. RC50 values (the concentration
required for 50% reduction of ABTS radical) were calcu-
lated from the absorbance diminished by 50%.
2,2′-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging
activity
Radical scavenging activity of extracts was determined
using DPPH as a free radical using the method described
by Moreno et al. [14], with some modifications. Briefly,
100 μL of various concentrations of sample was added
to 100 μL of DPPH solution (0.15 mM in ethanol) in a
96-well plate. After 30 min incubation in the dark at
room temperature, the absorbance was measured at
517 nm. Activity of scavenging (%) was calculated using
the above formula.
Model of asthma induced by OVA and treatment
Seven-week-old female BALB/c mice, obtained from
Orient Co. (Seoul, Korea), were used after 1 week of ac-
climation. All experimental procedures were conducted
in accordance with the NIH Guidelines for the Care and
Use of Laboratory Animals and were approved by Korea
Institute of Oriental Medicine Institutional Animal Care
and Use Committee. The animals were cared for in ac-
cordance with the dictates of the National Animal Wel-
fare Law of Korea. Mice were divided into five groups,
including a normal control group, an asthma model
group, a positive control group treated with montelukast
(30 mg/kg, Sigma, St. Louis, MO), and the ISSE-treated
group (100 and 200 mg/kg). Briefly, mice in the asthma
model group were sensitized with an intraperitoneal in-
jection of 20 μg OVA and 2 mg aluminum hydroxide in
200 μL PBS buffer (pH 7.4) on days 0 and 14. On days 21,
22, and 23 after initial sensitization, mice were challenged
with OVA (1%, w/v, in PBS) for 1 h using an ultrasonicFigure 1 Changes in the body weight of rats treated with ISSE for 15
ISSE to male (A) and female (B) rats.nebulizer (NE-U12; Omron Co., Tokyo, Japan). Mice in
the positive control and ISSE groups were treated orally
with montelukast and ISSE (100 mg/kg and 200 mg/kg),
respectively, once daily on days 18–23. Mice in the normal
control and asthma model groups were given PBS. Ani-
mals were sacrificed by intraperitoneal injection of pento-
barbital (50 mg/kg, Hanlim Pharm., Seoul, Korea) 48 h
after the final challenge.
Inflammatory cell counts in bronchoalveolar lavage fluid
(BALF)
Mice were sacrificed with an overdose of pentobarbital
48 h after the final challenge. BALF was collected by
washing lungs with ice-cold PBS (total volume of 1.8 mL)
via tracheal cannulation. BALF was centrifuged and cell
pellets were resuspended in 0.5 mL PBS, and cells in
100 μL of each solution spun onto a slide using a cytos-
pin device (Hanil Science Industrial, Seoul, Korea).
After the slides were dried, cells were stained using
Diff-Quik Staining reagent (B4132-1A; Dade Behring,
Deerfield, IL), according to the manufacturer’s instructions.
Measurement of cytokines and chemokine levels in BALF
The concentrations of IL-4, IL-5, and eotaxin in BALF of
mice were measured using enzyme-linked immunosorbent
assay (ELISA) kits following the manufacturer’s instruc-
tions (BioSource International, Camarillo, CA, USA).
Detection of OVA-specific immunoglobulin (Ig)E levels in
BALF and serum
Serum was collected and stored at −70°C after centrifuga-
tion (200 g, 10 min). Total and OVA-specific IgE levels
were measured by ELISA. Microtiter plates were coated
overnight with 10 μg/mL OVA in PBS-Tween 20. After
washing and blocking the plate, samples were incubated
for 2 h, and then HRP-conjugated goat anti-mouse IgE was
added. After washing, 200 μL of o-phenylenediamine dihy-
drochloride (Sigma, St. Louis, MO) was added to each well.days. Time course of mean body weight after oral administration of
Table 3 Scavenging effects of ISSE on DPPH
Herbal formula Concentration Scavenging effect RC50
1
(μg/mL) (%) (μg/mL)
ISSE2 50 1.55 ± 0.53 346.93 ± 3.28
100 8.58 ± 0.59
200 26.48 ± 0.61
400 58.58 ± 0.52
AA3 2.5 9.56 ± 1.26 10.43 ± 0.23
5 24.27 ± 1.40
10 58.79 ± 0.70
1Concentration required for 50% reduction of DPPH at 30-min reaction.
2Insampaedok-san and 3ascorbic acid.
Each value is the mean ± S.E.M. of triplicate determinations.
Table 2 Scavenging effects of ISSE on ABTS⋅ +
Herbal formula Concentration Scavenging effect RC50
1
(μg/mL) (%) (μg/mL)
ISSE2 25 18.20 ± 1.33 121.65 ± 0.88
50 29.48 ± 0.86
100 49.98 ± 0.61
200 71.85 ± 0.06
AA3 1.25 21.15 ± 0.19 3.22 ± 0.06
2.5 40.61 ± 1.44
5 75.86 ± 1.06
1Concentration required for 50% reduction of ABTS⋅ + at 5-min reaction.
2Insampaedok-san and 3ascorbic acid.
Each value is the mean ± S.E.M. of triplicate determinations.
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measured at 450 nm using a microplate ELISA reader.Measurement of superoxide dismutase (SOD) level in
lung tissue
The homogenates of lung tissues were centrifuged at
12,000 g for 20 min to collect supernatants for determin-
ation of SOD activity. SOD activity was assayed using a kit
according to the manufacturer’s instructions (Cayman,
Michigan, CA). SOD activity was determined with a modi-
fied method using a NADH-phenazine methosulfate-
nitroblue tetrazolium formazan inhibition reaction, which
was measured spectrophotometrically at 560 nm.Histopathology
After BALF were obtained, lung tissue was removed,
fixed with 10% (v/v) neutral buffered formalin. Tissues
were embedded in paraffin, sectioned at 4 μm thickness,
and stained with hematoxylin and eosin (H&E) (Sigma,
St. Louis, MO) and periodic acid–Schiff (PAS) solution
(IMEB, San Marcos, CA) to assess inflammation andFigure 2 Effects of ISSE on the recruitment of inflammatory cells in b
collected 48 h after final OVA challenge. Cell numbers within at least five s
Dead cells were excluded using trypan blue staining. NC, negative control
(30 mg/kg) + OVA-sensitized/challenged mice; ISSE-100, ISEE (100 mg/kg) +
sensitized/challenged mice. Significantly different from NC, #P < 0.05, ##P < 0mucus production, respectively. Tissue sections were ex-
amined microscopically.Statistical analysis
Data are expressed as means ± S.E.M. Statistical compari-
sons were made using a one-way analysis of variance
(ANOVA). P < 0.05 was considered statistically significant.Results
Acute oral toxicity study of ISSE in rats
No rats died during the 15-day acute toxicity study.
There was no significant difference in body weight of ei-
ther male or female rats between the ISSE-treated group
and the control group during the 15-day observation
period (Figure 1). No abnormal signs regarding general
appearance, behavior, or nervous system were observed
in rats from the ISSE-treated group compared with the
control group rats. Moreover, we did not detect any clin-
ical signs of adverse effects or any abnormal gross aut-
opsy findings induced by ISSE treatment for 15 days.ronchoalveolar lavage fluid (BALF) of mice. Mouse BALF was
quares of a hemocytometer were counted using a light microscope.
(PBS only); OVA, OVA-sensitized/challenged mice; Mon, montelukast
OVA-sensitized/challenged mice; ISSE-200, ISEE (200 mg/kg) + OVA-
.01; significantly different from OVA, *P < 0.05, **P < 0.01.
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To evaluate the antioxidant activity of ISSE, we tested its
scavenging activities on ABTS and DPPH radicals. ABTS
radical scavenging activities of ISSE are presented inFigure 3 Effects of ISSE on the recruitment of inflammatory cells to lu
of lung tissues was performed 48 h after the final OVA challenge. Lung tiss
only); OVA, OVA-sensitized/challenged mice; Mon, montelukast (30 mg/kg)
sensitized/challenged mice; ISSE-200, ISEE (200 mg/kg) + OVA-sensitized/chTable 2 as a percentage of ABTS radical scavenging ac-
tivity. ISSE showed the radical scavenging activity in a
dose-dependent manner. The scavenging activities of
ISSE were 18.19, 29.48, 49.98, and 71.85% at 25, 50, 100,ng tissue (A) and mucus production (B). Histological examination
ues were stained with H&E (A) and PAS (B). NC, negative control (PBS
+ OVA-sensitized/challenged mice; ISSE-100, ISEE (100 mg/kg) + OVA-
allenged mice.
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centration required for 50% reduction (RC50) against
ABTS radicals was 121.65 μg/mL, whereas the RC50 value
of ascorbic acid, as the positive control, was 3.22 μg/mL.
The antioxidant activities obtained for ISSE using the
DPPH method are shown in Table 3. Similar to the ABTS
assay, ISSE reduced the DPPH radical formation in aFigure 4 Effects of ISSE on IL-4, IL-5, and eotaxin levels in BALF. IL-4 (
negative control (PBS only); OVA, OVA-sensitized/challenged mice; Mon, m
(100 mg/kg) + OVA-sensitized/challenged mice; ISSE-200, ISEE (200 mg/kg)
#P < 0.05, ##P < 0.01; significantly different from OVA, *P < 0.05, **P < 0.01.concentration-dependent manner. The RC50 for ISSE
against DPPH radicals was 346.93 μg/mL, whereas the
RC50 value of ascorbic acid was 10.43 μg/mL.
Effect of ISSE on cell numbers in BALF
Inflammatory cells infiltrate the airways and secrete
various cytokines and mediators that aggravate airwayA), IL-5 (B), and eotaxin (C) levels were measured using an ELISA. NC,
ontelukast (30 mg/kg) + OVA-sensitized/challenged mice; ISSE-100, ISEE
+ OVA-sensitized/challenged mice. Significantly different from NC,
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and other inflammatory cells significantly increased in
the BALF of OVA-challenged mice. By contrast, ISSE
significantly suppressed recruitment of eosinophils and
lymphocytes in the lungs (Figure 2).
Effects of ISSE on inflammatory cell recruitment and
mucus production in lung tissue
Inflammatory cell recruitment and mucus secretion in lung
tissue were observed via microscopic examination. H&E-
stained lung tissue from the OVA-challenged mice showed
widespread eosinophil-rich inflammation in peribronchio-
lar and perivascular regions, and airspaces. Administration
of ISSE attenuated inflammatory cell infiltration compared
with the OVA-challenged group (Figure 3A).
In lung sections stained with PAS, mucus overproduction
was observed in bronchial airways of OVA-challenged mice.Figure 5 Effects of ISSE on the levels of OVA-specific IgE in BALF and
OVA-specific IgE level in BALF (B) OVA-specific IgE level in serum. NC, nega
montelukast (30 mg/kg) + OVA-sensitized/challenged mice; ISSE-100, ISEE (1
kg) + OVA-sensitized/challenged mice. Significantly different from NC, #P < 0The mucus staining was reduced in a dose-dependent man-
ner in the lung tissue of mice from the ISSE-treated group
(Figure 3B).Effects of ISSE on cytokines and chemokines in the BALF
of OVA-challenged mice
To investigate whether ISSE affects Th2 cytokine and che-
mokine secretion, we measured IL-4, IL-5, and eotaxin
levels in the BALF of mice. As shown in Figure 4, OVA
challenge induced a significant increase in the levels of IL-4
and IL-5 in BALF. However, the levels of IL-4 and IL-5
were decreased in ISSE-treated mice. Similar to the cyto-
kine levels, eotaxin levels increased in the BALF of OVA-
challenged mice compared with those in PBS-treated mice,
while the levels of eotaxin were decreased in the ISSE-
treated group.plasma. OVA-specific IgE levels were measured using an ELISA. (A)
tive control (PBS only); OVA, OVA-sensitized/challenged mice; Mon,
00 mg/kg) + OVA-sensitized/challenged mice; ISSE-200, ISEE (200 mg/
.05, ##P < 0.01; significantly different from OVA, *P < 0.05, **P < 0.01.
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serum
To investigate the effect of ISSE on the antibody re-
sponse to allergens, the serum and BALF levels of OVA-
specific IgE were measured using an ELISA. The level of
OVA-specific IgE was elevated in the serum and BALF
of OVA-challenged mice compared with the control
group. ISSE treatment resulted in a reduction in the
levels of OVA-specific IgE (Figure 5).
Effect of ISSE on SOD activity and HO-1 activity in lung
tissue
To investigate the antioxidant effect of ISSE, we deter-
mined SOD activity in lung tissue. SOD activity was
downregulated in mice from the asthma model group.
ISSE treatment led to a marked increase in SOD activity
(Figure 6).
Discussion
Traditional herbal medicine has a history of thousands
of years and is still widely used in Korea and China. The
evolution of traditional herbal medicine is based on ob-
servations and practical experience accumulated from
millions of practitioners for thousands of years [15]. Be-
cause traditional herbal medicine does not have its own
history of scientific development, there is little scientific
research conducted on the safety of herbal formulas.
Herbal medicines have often been provided to humans
without scientifically rigorous toxicity testing. Recently,
adverse effects of herbal medicines have been reported
[15,16]. Therefore, herbal medicine toxicity studies are
needed to evaluate their safety. In the present study, we
performed an acute oral toxicity study of ISSE, which is
used often in respiratory diseases. ISSE was given orallyFigure 6 Effects of ISSE on SOD activity in lung tissue. SOD
activity was measured using a kit. NC, negative control (PBS only); OVA,
OVA-sensitized/challenged mice; Mon, montelukast (30 mg/kg) +
OVA-sensitized/challenged mice; ISSE-100, ISEE (100 mg/kg) + OVA-
sensitized/challenged mice; ISSE-200, ISEE (200 mg/kg) + OVA-sensitized/
challenged mice. Significantly different from NC, #P< 0.05, ##P< 0.01;
significantly different from OVA, *P < 0.05, **P < 0.01.to SD rats of both sexes at dose levels of 0 and 5000 mg/kg
and they were observed for 15 days. Our results showed
that no deaths occurred in either the vehicle-only control
group or the ISSE group. The administration of ISSE did
not cause an increase or decrease in rat body weight, when
compared with the control group. In addition, there were
no abnormal changes in clinical signs or gross observation.
Overall, ISSE did not cause any adverse effects in this
study; therefore, the LD50 of ISSE was considered to be
over 5000 mg/kg for oral administration in rats.
ISS has been widely used for thousands of years in
China and Korea to treat patients with respiratory dis-
eases. Clinical trials show that ISS has a beneficial effect
on the treatment of asthma [10,11]. To evaluate its anti-
asthmatic effects, we performed an in vitro study on free
radical scavenging activities of ISS and an in vivo study
using a model of asthma induced by OVA in mice. Oxi-
dative stress is a major feature of asthma. Many investiga-
tors have reported that increased levels of ROS in the
asthmatic inflammatory process aggravate airway inflam-
mation and damages molecules, such as proteins, DNA,
and lipids [17,18]. It has therefore been suggested that a
combination of antioxidants may have positive impact on
the treatment of asthma [4]. ISS is composed of 12 herbs,
Radix Ginseng, Bupleuri Radix, Angelica decursiva Radix,
Osterici Radix, Aralia continentalis Radix, Aurantii Fructus
Immaturus, Platycodonis Radix, Cnidii Rhizoma, Poria
Sclerotium, Glycyrrhizae Radix et Rhizoma, Menthae
Herba, and Zingiberis Rhizoma Crudus. Also, ISS is com-
posed various compounds such as liquiritin, ferulic acid,
naringin, hesperidin, neohesperidin, and glycyrrhizin. Sev-
eral components of ISS, such as Ginseng Radix [19], Aralia
continentalis Radix [20], Aurantii Fructus Immaturus [21],
Platycodonis Radix [22], and Cnidii Rhizoma [23], have
been reported to possess antioxidant effects. Therefore, we
investigated the total free radical scavenging activity of
ISSE using DPPH and ABTS assays, which involve a
hydrogen atom transfer reaction and electron transfer
process, respectively [24]. As shown in the results, ISSE
showed both DPPH and ABTS radical scavenging activ-
ities. Shanmugasundaram et al. have reported that exces-
sive superoxide (O2
⋅ −) and hydroxyl (⋅OH) radical and
reduced free radical scavengers (vitamin C, E, glutathione)
and antioxidant enzymes (SOD, glutathione peroxidase,
catalase were observed in the blood of asthmatic children
during asthmatic episodes and interictally [25]. Our results
indicate that ISSE is a potential source of natural antioxi-
dant, which might be helpful in lowering oxidative stress.
We investigated the antiasthmatic effects of ISSE and
its possible mechanism using a model of asthma induced
by OVA in mice. ISSE markedly inhibited infiltration of
inflammatory cells and overproduction of mucus in lung
tissue. In addition, ISSE treatment resulted in a reduc-
tion in the levels of IL-4, IL-5, and eotaxin in BALF, and
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creased SOD activity in lung tissue.
The major feature of asthma is an airway inflamma-
tion, in which CD4 T-lymphocytes, eosinophils and mast
cells are predominantly involved [26]. ISSE mainly de-
creased the numbers of lymphocytes, which regulate
other effector cells in the pathogenesis of asthma [27],
and eosinophils, which reflect asthmatic activity and se-
verity of asthma [27,28], in BALF. This reduction of lym-
phocytes may be related to the inhibitory effects of ISSE
on IL-4, IL-5, and eotaxin, which induce migration and
recruitment of these cells to the airways. IL-4 promotes
inflammation by inducing the differentiation of Th2
cells, and expression of ICAM-1 and VCAM-1 on endo-
thelial cells, which increases lung cell infiltration [29,30].
IL-5 induces growth, maturation, activation, migration,
and survival of eosinophils [31]. IL-5 mRNA levels in
asthmatics has a high correlation with eosinophils, air-
way hyperresponsiveness, and exhaled nitric oxide levels,
which reflect airway inflammation [32]. Eotaxins are po-
tent eosinophil chemoattractants stimulated by IL-4, IL-
5, and IL-13 [33]. Therefore, the inhibition of eosinophil
infiltration may result from less production of eotaxin
and IL-5 after administration of ISSE.
Th2 cytokines are also involved in airway hyperrespon-
siveness and mucus production [34]. IL-4 stimulates IgE
production from B lymphocytes [29]. Antigen-specific IgE
binds to receptors on mast cells and sensitizes them to re-
lease mediators [35]. Activated mast cells produce diverse
mediators and cytokines, which promote a hypersensitivity
response characterized by contraction of bronchial smooth
muscle, mucosal edema, and mucus hypersecretion [36].
Mucus hypersecretion, an important feature of asthma, is
induced by eosinophils and mast-cell products [37] and
goblet-cell metaplasia [34]. IL-4 and IL-5 lead to activation
and infiltration of inflammatory cells. Moreover, IL-4
has the ability to differentiate airway epithelial cells into
mucus-producing goblet cells [38]. In the present study,
ISSE decreased OVA-specific IgE levels and mucus
overproduction; this finding is consistent with its effect
on Th2 cytokines.
Activated inflammatory cells can produce O2
⋅ − and
several inflammatory mediators that stimulate or pro-
mote ROS generation, which causes direct damage to
tissue and cells [39] and aggravates inflammation by ac-
tivation of nuclear factor kappa-B (NF-κB) [40]. SOD, an
antioxidant enzyme, protects the airway from oxidant
stress. However, SOD activity decreased in the oxidant-
rich environment of asthma, which contributes to airway
remodeling and hyperreactivity of asthma [41]. We show
here that ISSE increased SOD activity compared with
OVA group. This further supports that the antiasthmatic
effects of ISSE are at least partially mediated by its anti-
oxidant activity.This finding indicates that ISSE enhances SOD pro-
duction, which might mediate inhibitory effects of ISSE
on inflammation and produce synergistic effects for the
treatment of asthma through its antioxidant activity.
Conclusions
The acute oral toxicity study in rats showed no adverse
effects of ISSE up to a dose level of 5000 mg/kg in rats.
The present study suggests that the beneficial effect of
ISSE on asthma is associated with its antioxidant and
anti-inflammatory activities. ISSE has free radical scav-
enging activity in vitro, and enhances SOD activity in
lung tissue in a model of asthma in mice. ISSE suppresses
inflammation induced by asthma by reducing infiltration
of inflammatory cells, production of Th2 cytokines, che-
mokine, and antigen-specific IgE, and attenuating mucus
hypersecretion. This study provides information regarding
the safety and mechanism of antiasthmatic effects of ISSE.
However, further research on constituents compounds’s
activity and chronic toxicity are required.
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